Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Potent, selective human A2B adenosine receptor antagonists reported

Aug. 22, 2000

Suplatast tosilate improves asthma symptoms in a double-blind trial

Aug. 22, 2000

Novel PCP inhibitors under development at Roche

Aug. 16, 2000

Janssen receives patent for new antihistaminic series

Aug. 11, 2000

Pulmicort Respules approved in U.S. for children aged 1 to 8 years

Aug. 9, 2000

MSI-ipratropium trial reveals efficacy of new delivery system

Aug. 9, 2000

New alpha4-integrin antagonists useful for asthma, etc.

Aug. 8, 2000

New compounds interacting with chemokine receptors under study at DuPont

Aug. 7, 2000

Texas Biotechnology announces initial financing of Revotar subsidiary

Aug. 4, 2000

New compounds under development at AHP for treatment of inflammatory and autoimmune diseases

Aug. 3, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.